#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune myositis Necrotising enterocolitis neonatal Activated PI3 kinase delta syndrome Craniopharyngioma Lennox-Gastaut syndrome Acute lymphocytic leukaemia recurrent Systemic scleroderma Angelman's syndrome Cholestatic pruritus CDKL5 deficiency disorder Glioblastoma Chondrosarcoma Fragile X syndrome Deafness neurosensory Noonan syndrome More trials…

    Learn about Rare Diseases

    Prolymphocytic leukaemia Hereditary ataxia – Life with Disease Hereditary hypophosphataemic rickets – Basic Information Primary immunodeficiency syndrome – Trials in Disease Isodicentric chromosome 15 syndrome – Basic Information Sjogren’s syndrome – Basic Information Malignant fibrous histiocytoma – Trials in Disease Proteus syndrome – Basic Information Idiopathic inflammatory myopathy – Life with Disease Niemann-Pick disease – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Chlorphenamine Linsitinib Dacomitinib Rilpivirine Olaparib TRAZODONE HYDROCHLORIDE Rineterkib Tavapadon Thiocolchicoside Avalglucosidase Alfa Ck-0045 Octreotide Hydrochloride Bgb-A445 VANADIUM OXIDE SULFATE [68GA]GA-NOTA-AE105 SOFTISAN 378 Abemaciclib Buparlisib Simeticone Melphalan More therapies…

    Learn about Your Condition

    Adenocarcinoma of colon Neutropenia Genital herpes simplex Myxoid liposarcoma Eye disorder Eosinophilic oesophagitis Polyneuropathy Nodular melanoma Hypopituitarism Bronchitis Labour induction Escherichia infection B-cell lymphoma Hepato-lenticular degeneration Obsessive-compulsive disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Long-Term Safety of Aficamten (CK-3773274) for Patients with Symptomatic Hypertrophic Cardiomyopathy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hypertrophic cardiomyopathy
    Investigated Drugs:
    • Aficamten
    Czechia Denmark France Germany Greece Hungary +6

  • Study of Durvalumab alone and in combination with Tremelimumab in children with advanced solid tumors and blood cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Tremelimumab
    • Durvalumab
    Spain

  • Study on the Safety and Tolerability of CEB-01 in Patients with Pancreatic Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • 7-Ethyl-10-Hydroxycamptothecin
    Spain

  • Study on the Effects of Ozanimod in Patients with Relapsing-Remitting Multiple Sclerosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Multiple sclerosis relapse
    • Multiple sclerosis
    Investigated Drugs:
    • Ozanimod Hydrochloride
    Italy

  • Study on Self-Administration of Elranatamab for Patients with Multiple Myeloma at Home

    Recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Elranatamab
    Denmark

  • Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn’s Disease

    Recruiting

    2 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Zasocitinib
    Belgium Bulgaria Czechia Denmark France Germany +8
Previous Page
1 … 515 516 517 518 519 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!